Study: Vioxx poses even short-term risks

A Montreal study raises questions about even short-term use of the pain drug Vioxx and may harm Merck & Co.'s defense against 11,500 lawsuits, a report said.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news65896449.html">Study: Vioxx poses even short-term risks</a></p> <p>A Montreal study raises questions about even short-term use of the pain drug Vioxx and may harm Merck & Co.'s defense against 11,500 lawsuits, a report said. </p>